5P01AG017617-20 |
2021 |
$159598 |
8554 |
Core A: Administrative Core |
NIXON, RALPH A. |
5P01AG017617-20 |
2021 |
$461737 |
8555 |
Core B: Mouse models Core |
LEVY, EFRAT |
5P01AG017617-20 |
2021 |
$357524 |
8556 |
Core C: Analytical Core |
NIXON, RALPH A. |
5P01AG017617-20 |
2021 |
$292712 |
8557 |
Modulation of endosomal pathway dysfunction in Alzheimer's disease |
MATHEWS, PAUL M. |
5P01AG017617-20 |
2021 |
$523587 |
8558 |
Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation |
NIXON, RALPH A. |
5P01AG017617-20 |
2021 |
$279393 |
8559 |
Regulation of extracellular vesicle secretory pathways in Alzheimer's disease |
LEVY, EFRAT |
5P01AG017617-20 |
2021 |
$350418 |
8560 |
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function |
GINSBERG, STEPHEN D. |
5P01AG017617-19 |
2020 |
$525606 |
8558 |
Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation |
NIXON, RALPH A. |
5P01AG017617-19 |
2020 |
$279393 |
8559 |
Regulation of extracellular vesicle secretory pathways in Alzheimer's disease |
LEVY, EFRAT |
5P01AG017617-19 |
2020 |
$350418 |
8560 |
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function |
GINSBERG, STEPHEN D. |
3P01AG017617-19S1 |
2020 |
$249884 |
None |
Cell and Molecular Pathobiology of Alzheimer's Disease |
NIXON, RALPH A. |
5P01AG017617-19 |
2020 |
$159598 |
8554 |
Core A: Administrative Core |
NIXON, RALPH A. |
5P01AG017617-19 |
2020 |
$461737 |
8555 |
Core B: Mouse models Core |
LEVY, EFRAT |
5P01AG017617-19 |
2020 |
$357524 |
8556 |
Core C: Analytical Core |
NIXON, RALPH A. |
5P01AG017617-19 |
2020 |
$292712 |
8557 |
Modulation of endosomal pathway dysfunction in Alzheimer's disease |
MATHEWS, PAUL M. |
5P01AG017617-18 |
2019 |
$159598 |
8554 |
Core A: Administrative Core |
NIXON, RALPH A. |
5P01AG017617-18 |
2019 |
$461738 |
8555 |
Core B: Mouse models Core |
LEVY, EFRAT |
5P01AG017617-18 |
2019 |
$357524 |
8556 |
Core C: Analytical Core |
NIXON, RALPH A. |
5P01AG017617-18 |
2019 |
$292711 |
8557 |
Modulation of endosomal pathway dysfunction in Alzheimer's disease |
MATHEWS, PAUL M. |
5P01AG017617-18 |
2019 |
$529038 |
8558 |
Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation |
NIXON, RALPH A. |
5P01AG017617-18 |
2019 |
$279393 |
8559 |
Regulation of extracellular vesicle secretory pathways in Alzheimer's disease |
LEVY, EFRAT |
5P01AG017617-18 |
2019 |
$350418 |
8560 |
Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function |
GINSBERG, STEPHEN D. |
5P01AG017617-17 |
2018 |
$357524 |
8556 |
Core C: Analytical Core |
NIXON, RALPH A. |
5P01AG017617-17 |
2018 |
$292711 |
8557 |
Modulation of endosomal pathway dysfunction in Alzheimers disease |
MATHEWS, PAUL M. |
5P01AG017617-17 |
2018 |
$529038 |
8558 |
Molecular basis of lysosomal dysfunction in Alzheimers disease and approaches to therapeutic remediation |
NIXON, RALPH A. |
5P01AG017617-17 |
2018 |
$279393 |
8559 |
Regulation of extracellular vesicle secretory pathways in Alzheimers disease |
LEVY, EFRAT |
5P01AG017617-17 |
2018 |
$350418 |
8560 |
Uncovering Alzheimers disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function |
GINSBERG, STEPHEN D. |
5P01AG017617-17 |
2018 |
$159598 |
8554 |
Core A: Administrative Core |
NIXON, RALPH A. |
5P01AG017617-17 |
2018 |
$461738 |
8555 |
Core B: Mouse models Core |
LEVY, EFRAT |
2P01AG017617-16 |
2017 |
$2443714 |
None |
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
2P01AG017617-16 |
2017 |
$159598 |
8554 |
Core A: Administrative Core |
NIXON, RALPH A. |
2P01AG017617-16 |
2017 |
$461736 |
8555 |
Core B: Mouse models Core |
LEVY, EFRAT |
2P01AG017617-16 |
2017 |
$357522 |
8556 |
Core C: Analytical Core |
NIXON, RALPH A. |
2P01AG017617-16 |
2017 |
$290250 |
8557 |
Modulation of endosomal pathway dysfunction in Alzheimers disease |
MATHEWS, PAUL M. |
2P01AG017617-16 |
2017 |
$546700 |
8558 |
Molecular basis of lysosomal dysfunction in Alzheimers disease and approaches to therapeutic remediation |
NIXON, RALPH A. |
2P01AG017617-16 |
2017 |
$277490 |
8559 |
Regulation of extracellular vesicle secretory pathways in Alzheimers disease |
LEVY, EFRAT |
2P01AG017617-16 |
2017 |
$350418 |
8560 |
Uncovering Alzheimers disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal function |
GINSBERG, STEPHEN D. |
3P01AG017617-15S1 |
2016 |
$674732 |
None |
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-15 |
2015 |
$442212 |
6302 |
AUTOPHAGY FUNCTION AND DYSFUNCTION IN ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-15 |
2015 |
$223576 |
6303 |
EXOSOMAL SECRETION AND CYSTATIN C, INHIBITORS OF NEURONAL ABNORMALITIES IN AD |
NIXON, RALPH A. |
5P01AG017617-15 |
2015 |
$297529 |
6304 |
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD |
GINSBERG, STEPHEN D. |
5P01AG017617-15 |
2015 |
$234441 |
6320 |
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY |
NIXON, RALPH A. |
5P01AG017617-15 |
2015 |
$219432 |
6300 |
TRANSGENIC CORE |
LEVY, EFRAT |
5P01AG017617-15 |
2015 |
$181959 |
6299 |
ADMINISTRATIVE CORE |
NIXON, RALPH A. |
5P01AG017617-15 |
2015 |
$317565 |
6301 |
ANALYTICAL CORE |
NIXON, RALPH A. |
5P01AG017617-14 |
2014 |
$187585 |
6299 |
ADMINISTRATIVE CORE |
NIXON, RALPH A. |
5P01AG017617-14 |
2014 |
$327386 |
6301 |
ANALYTICAL CORE |
NIXON, RALPH A. |
5P01AG017617-14 |
2014 |
$455889 |
6302 |
AUTOPHAGY FUNCTION AND DYSFUNCTION IN ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-14 |
2014 |
$230491 |
6303 |
EXOSOMAL SECRETION AND CYSTATIN C, INHIBITORS OF NEURONAL ABNORMALITIES IN AD |
NIXON, RALPH A. |
5P01AG017617-14 |
2014 |
$306732 |
6304 |
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD |
GINSBERG, STEPHEN D. |
5P01AG017617-14 |
2014 |
$241693 |
6320 |
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY |
NIXON, RALPH A. |
5P01AG017617-14 |
2014 |
$226218 |
6300 |
TRANSGENIC CORE |
LEVY, EFRAT |
5P01AG017617-13 |
2013 |
$177269 |
6299 |
ADMINISTRATIVE CORE |
NIXON, RALPH A. |
5P01AG017617-13 |
2013 |
$309381 |
6301 |
ANALYTICAL CORE |
NIXON, RALPH A. |
5P01AG017617-13 |
2013 |
$430817 |
6302 |
AUTOPHAGY FUNCTION AND DYSFUNCTION IN ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-13 |
2013 |
$217813 |
6303 |
EXOSOMAL SECRETION AND CYSTATIN C, INHIBITORS OF NEURONAL ABNORMALITIES IN AD |
NIXON, RALPH A. |
5P01AG017617-13 |
2013 |
$289861 |
6304 |
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD |
GINSBERG, STEPHEN D. |
5P01AG017617-13 |
2013 |
$228398 |
6320 |
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY |
NIXON, RALPH A. |
5P01AG017617-13 |
2013 |
$213777 |
6300 |
TRANSGENIC CORE |
LEVY, EFRAT |
5P01AG017617-12 |
2012 |
$187585 |
6299 |
ADMINISTRATIVE CORE |
NIXON, RALPH A. |
5P01AG017617-12 |
2012 |
$327386 |
6301 |
ANALYTICAL CORE |
NIXON, RALPH A. |
5P01AG017617-12 |
2012 |
$455889 |
6302 |
AUTOPHAGY FUNCTION AND DYSFUNCTION IN ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-12 |
2012 |
$1975994 |
None |
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-12 |
2012 |
$306732 |
6304 |
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD |
GINSBERG, STEPHEN D. |
5P01AG017617-12 |
2012 |
$241693 |
6320 |
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY |
NIXON, RALPH A. |
5P01AG017617-12 |
2012 |
$226218 |
6300 |
TRANSGENIC CORE |
LEVY, EFRAT |
5P01AG017617-12 |
2012 |
$230491 |
6303 |
EXOSOMAL SECRETION AND CYSTATIN C, INHIBITORS OF NEURONAL ABNORMALITIES IN AD |
NIXON, RALPH A. |
2P01AG017617-11A1 |
2011 |
$1995905 |
None |
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
3P01AG017617-10S2 |
2011 |
$435000 |
None |
CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-10 |
2009 |
$374785 |
9003 |
ANALYTICAL CORE |
NIXON, RALPH A. |
5P01AG017617-10 |
2009 |
$461709 |
6 |
AUTOPHAGY FUNCTION AND DYSFUNCTION IN ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-10 |
2009 |
$287716 |
7 |
CYSTATIN C INHIBITOR OF NEURONAL ABNORMALITIES IN AD |
LEVY, EFRAT |
5P01AG017617-10 |
2009 |
$369889 |
8 |
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD |
GINSBERG, STEPHEN D. |
5P01AG017617-10 |
2009 |
$417011 |
5 |
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY |
MATHEWS, PAUL M. |
5P01AG017617-10 |
2009 |
$230728 |
9001 |
TRANSGENIC CORE |
LEVY, EFRAT |
5P01AG017617-09 |
2008 |
$338379 |
9003 |
ANALYTICAL CORE |
NIXON, RALPH A. |
5P01AG017617-09 |
2008 |
$333362 |
8 |
EXPRESSION PROFILING OF ENDOSOMAL PATHWAYS IN AD |
GINSBERG, STEPHEN D. |
5P01AG017617-09 |
2008 |
$416119 |
6 |
AUTOPHAGY FUNCTION AND DYSFUNCTION IN ALZHEIMER'S DISEASE |
NIXON, RALPH A. |
5P01AG017617-09 |
2008 |
$259308 |
7 |
CYSTATIN C INHIBITOR OF NEURONAL ABNORMALITIES IN AD |
LEVY, EFRAT |
5P01AG017617-09 |
2008 |
$375840 |
5 |
THE ORIGINS OF ENDOSOME DYSFUNCTION IN AD PATHOBIOLOGY |
MATHEWS, PAUL M. |
5P01AG017617-09 |
2008 |
$207945 |
9001 |
TRANSGENIC CORE |
LEVY, EFRAT |